Saturday, December 12, 2015
close

Top Medical News from Across Medscape

  • Cancers May Impair Heart Function: More EvidenceTreated and nontreated cancer patients had similarly reduced cardiac strain, which may suggest that "some inflammatory components to the tumor growth affect the heart muscle," say researchers.
  • Biosimilar Drugs Will Disrupt GastroenterologyThe arrival of low-cost biosimilar treatments in the United States is imminent, but some gastroenterologists have questions about the immunogenicity and interchangeability of the agents.
  • Neratinib Keeps Benefiting Herceptin-Treated Breast CancerNew results from the ExteNET study of the investigational drug neratinib following adjuvant trastuzumab chemotherapy confirm a benefit of the agent beyond the previously reported 2-year results.
  • Obesity 'a National Risk'The chief medical officer for England says obesity needs to be given the official status of a 'national risk'.

Special Report

  • Medscape held its first Medicine 3.0 event in New York City. The Town Hall-style discussion featured a panel of physician experts on the topics of precision medicine and patient engagement.

Business of Medicine

  • Dermatologists Wary Despite Low Malpractice Risks; More Liability concerns affect even the least likely to be sued; these doctors want to see the public vote on caps; hospital's failure to diagnose leads to a fat award.
  • Should Patients Call You by Your First Name? In an age where everyone seems to lean toward being less formal, many physicians still don't feel comfortable with patients using their first name in medical settings. Your colleagues weigh in.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California
All material on this website is protected by copyright, Copyright © 1994-2015 by WebMD LLC. This website also contains material copyrighted by 3rd parties.